GSK: Singapore gives nod to GSK's Omjjara (momelotinib) as first treatment indicated for myelofibrosis patients with anaemia

GSK is an England-based multinational biopharmaceutical company that develops and markets medicinal drugs and vaccines for the treatment of a variety of diseases.